Literature DB >> 6178543

The effect of cyclosporin A on the adoptive transfer of experimental allergic encephalomyelitis in the Lewis rat.

C Bolton, G Allsopp, M L Cuzner.   

Abstract

Experimental allergic encephalomyelitis (EAE) can be adoptively transferred in Lewis rats with spleen cells from immunized animals, after culture with concanavalin A or myelin basic protein (MBP). The effect of the immunosuppressive drug cyclosporin A (CsA) on the in vitro and in vivo steps of the cell transfer has been investigated. Clinical signs of EAE were completely suppressed by CsA in rats immunized with MBP in Freund's complete adjuvant and spleen cells from these animals, cultured with the antigen, did not transfer the disease. The incidence of transferred disease was also reduced, if recipients were treated with CsA, although a higher dose of drug than that needed to suppress active EAE was required. In both instances complete suppression of EAE was only accomplished for the period of dosing, although the clinical signs of disease which appeared after withdrawal of the drug were significantly reduced in severity. These results imply that an immune response in the host animal is a prerequisite for adoptive transfer of EAE or suggest that CsA can regulate the action of lymphocytes already primed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6178543      PMCID: PMC1536363     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  11 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  Studies on the mechanism of action of cyclosporin A.

Authors:  D Wiesinger; J F Borel
Journal:  Immunobiology       Date:  1980-01       Impact factor: 3.144

3.  Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity.

Authors:  J F Borel
Journal:  Immunology       Date:  1976-10       Impact factor: 7.397

4.  Autoimmune effector cells. I. Transfer of experimental encephalomyelitis with lymphoid cells cultured with antigen.

Authors:  J H Holda; A M Welch; R H Swanborg
Journal:  Eur J Immunol       Date:  1980-08       Impact factor: 5.532

5.  Adoptive transfer of experimental allergic encephalomyelitis with activated spleen cells: comparison of in vitro activation by concanavalin a and myelin basic protein.

Authors:  H S Panitch
Journal:  Cell Immunol       Date:  1980-11       Impact factor: 4.868

6.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

Authors:  G E Deibler; R E Martenson; M W Kies
Journal:  Prep Biochem       Date:  1972

7.  Suppression of the hyperacute form of experimental allergic encephalomyelitis by drugs.

Authors:  S Levine; R Sowinski
Journal:  Arch Int Pharmacodyn Ther       Date:  1977-12

8.  Transfedotr of Allergic Encephalomyelitis by Lymph Node Cells in Inbred Guinea Pigs.

Authors:  S H Stone
Journal:  Science       Date:  1961-09-01       Impact factor: 47.728

9.  Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.

Authors:  J R Richert; B F Driscoll; M W Kies; E C Alvord
Journal:  J Immunol       Date:  1979-02       Impact factor: 5.422

10.  In vitro effects of cyclosporin A on lymphocyte subpopulations. 1. Suppressor cell sparing by cyclosporin A.

Authors:  S B Leapman; R S Filo; E J Smith; P G Smith
Journal:  Transplantation       Date:  1980-12       Impact factor: 4.939

View more
  15 in total

1.  The effect of cyclosporin A on the interstitial mononuclear cell infiltration and the induction of Heymann's nephritis.

Authors:  C Grönhagen-Riska; E von Willebrand; T Tikkanen; E Honkanen; A Miettinen; H Holthöfer; T Törnroth
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

2.  Immunosuppressive effect of cyclosporin A on Mycobacterium bovis BCG infections in mice.

Authors:  T Takashima; F M Collins
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

Review 3.  Multiple sclerosis. Current concepts in management.

Authors:  B Giesser
Journal:  Drugs       Date:  1985-01       Impact factor: 9.546

4.  Effects of cyclosporin A on humoral immune response and resistance against vesicular stomatitis virus in mice.

Authors:  S Charan; A W Huegin; A Cerny; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

5.  Suppression of delayed-type hypersensitivity reactions and lymphokine production by cyclosporin A in the mouse.

Authors:  A W Thomson; D K Moon; D S Nelson
Journal:  Clin Exp Immunol       Date:  1983-06       Impact factor: 4.330

6.  Characterisation of passively transferred antigen arthritis induced by methylated bovine serum albumin in the rat: effect of FK 506 on arthritis development.

Authors:  R J Griffiths; S W Li; M E Mather
Journal:  Agents Actions       Date:  1992-05

7.  Inhibition of programmed cell death by cyclosporin A; preferential blocking of cell death induced by signals via TCR/CD3 complex and its mode of action.

Authors:  D Yasutomi; C Odaka; S Saito; H Niizeki; H Kizaki; T Tadakuma
Journal:  Immunology       Date:  1992-09       Impact factor: 7.397

8.  The efficacy of cyclosporin A, FK-506 and prednisolone to modify the adoptive transfer of experimental allergic encephalomyelitis (EAE).

Authors:  C Bolton
Journal:  Agents Actions       Date:  1992-01

9.  Modification of delayed-type hypersensitivity reactions to ovalbumin in cyclosporin A-treated guinea-pigs.

Authors:  A W Thomson; D K Moon; Y Inoue; C L Geczy; D S Nelson
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

10.  Cyclosporin A induces long-term unresponsiveness in mercuric chloride-induced autoimmune glomerulonephritis.

Authors:  J Aten; C B Bosman; E De Heer; P J Hoedemaeker; J J Weening
Journal:  Clin Exp Immunol       Date:  1988-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.